Aspen Pharmacare Holdings Ltd represents a strong set of values and a clear corporate philosophy. The company aims to provide affordable medicines of high quality to people around the world, thus improving their health and well-being. Aspen Pharmacare values integrity, innovation, and accountability in all aspects of its operations. It focuses on sustainable growth and strategic partnerships to expand its global presence and reach. Aspen Pharmacare is committed to providing access to essential healthcare solutions and ensuring patient safety. With its dedicated workforce and commitment to excellence, Aspen Pharmacare continues to make a positive impact in the pharmaceutical industry.

Aspen Pharmacare Holdings Ltd is primarily present in various countries and regions worldwide. Some of the key markets where the company operates include South Africa, where it is headquartered, as well as other African countries such as Kenya, Nigeria, and Ethiopia. Additionally, Aspen Pharmacare has a significant presence in Latin American countries including Brazil and Mexico. The company has also expanded its operations into Europe, with a focus on countries like Germany, Spain, Italy, and the United Kingdom. Furthermore, Aspen Pharmacare has a presence in the Asia-Pacific region, including Australia, China, and India.

Aspen Pharmacare Holdings Ltd, a leading pharmaceutical company, has achieved several significant milestones. Over the years, the company has expanded its global presence and diversified its product portfolio. It has successfully acquired and integrated multiple companies, enhancing its market reach and capabilities. Aspen Pharmacare has also developed and launched innovative medicines, contributing to advancements in healthcare. The company has received numerous industry awards and recognition, further highlighting its commitment to excellence. With a strong focus on research and development, Aspen Pharmacare continues to make substantial contributions to the healthcare industry, delivering high-quality solutions to patients worldwide.

Aspen Pharmacare Holdings Ltd, commonly known as Aspen, is a leading global pharmaceutical company with a rich history and strong background. Founded in 1850 and headquartered in Durban, South Africa, Aspen has grown into a reputable player in the healthcare industry. The company specializes in the manufacturing and distribution of both branded and generic pharmaceutical products across various therapeutic areas. With a diversified portfolio, Aspen operates in more than 150 countries, serving patients and healthcare professionals worldwide. Over the years, Aspen has made strategic acquisitions and formed partnerships to expand its product offerings and global reach. With a commitment to improving patient lives, Aspen continues to drive innovation and deliver quality healthcare solutions globally.

The main competitors of Aspen Pharmacare Holdings Ltd in the market are Teva Pharmaceutical Industries Ltd, Mylan N.V., and Sun Pharmaceutical Industries Ltd.

Aspen Pharmacare Holdings Ltd is primarily active in the pharmaceutical industry.

The business model of Aspen Pharmacare Holdings Ltd is focused on the manufacturing and marketing of pharmaceutical and healthcare products. Aspen Pharmacare is a leading global supplier of branded and generic pharmaceuticals, as well as infant nutritionals and consumer healthcare products. With a diverse portfolio of products, the company operates across multiple therapeutic areas including anaesthetics, thrombosis, oncology, and respiratory. Aspen Pharmacare also engages in extensive research and development activities to drive innovation within the pharmaceutical industry. Its commitment to quality and affordability ensures the availability of essential medicines to a wide range of markets worldwide.

Aspen Pharmacare Holdings에 대한 현재 주가 수익 비율을 계산할 수 없습니다.

Aspen Pharmacare Holdings에 대한 현재 KUV는 계산할 수 없습니다.

Aspen Pharmacare Holdings에 대한 AlleAktien 품질 점수는 4/10입니다.

예상되는 Aspen Pharmacare Holdings 매출은 43.74 조. ZAR입니다.

예상되는 Aspen Pharmacare Holdings 이익은 7.18 조. ZAR입니다.

Aspen Pharmacare Holdings Ltd is an international pharmaceutical company based in South Africa. The company specializes in the production and distribution of pharmaceuticals, biopharmaceuticals, and active ingredients. It is one of the largest manufacturers of generics in Africa. The company's business model is characterized by intensive R&D work and a strong presence in Africa. It produces a wide range of pharmaceutical products for various fields such as psychiatry, oncology, gastroenterology, and pain therapy. Aspen is also a significant provider of veterinary medicines. One of the key aspects of its business model is the production of generics, offering cost-effective alternatives to branded products. This allows Aspen to establish a strong presence and achieve high market penetration in markets with limited investment requirements. The company has expanded its business in Europe and Asia, in addition to its strong presence in Africa. This geographical diversification allows Aspen to reach a broad customer base and minimize risks. Besides its products, Aspen also offers tailored services such as shipping, storage, and logistics management to ensure fast and efficient delivery to customers. The company has also expanded its presence in biopharmaceuticals through the acquisition of ThromboGenics in 2013, making it a leading provider of platelet activating factors. Aspen is committed to social responsibility and has initiated various initiatives to improve access to affordable medical products in Africa. Overall, Aspen Pharmacare Holdings Ltd's business model is based on its wide range of products and services, strategic focus on the African market, and effective implementation of its strategy, which has made it one of the largest and fastest-growing pharmaceutical companies in Africa.

Aspen Pharmacare Holdings은(는) 연간 번의 배당을 통해 3.26 ZAR의 배당금을 지급합니다.

Aspen Pharmacare Holdings의 현재 배당금은 계산할 수 없거나, 회사가 배당금을 지급하지 않습니다.

Aspen Pharmacare Holdings의 ISIN은 ZAE000066692입니다.

Aspen Pharmacare Holdings의 WKN은 A0ET80입니다.

Aspen Pharmacare Holdings의 티커는 APN.JO입니다.

지난 12개월 동안 Aspen Pharmacare Holdings은(는) 3.79 ZAR 의 배당금을 지급했습니다. 이는 약 의 배당 수익률에 해당합니다. 향후 12개월 동안 Aspen Pharmacare Holdings은(는) 4.05 ZAR의 배당금을 지급할 것으로 예상됩니다.

Aspen Pharmacare Holdings의 현재 배당 수익률은 입니다.

Aspen Pharmacare Holdings은 분기별로 배당금을 지급합니다. 이는 , , , 월에 배당됩니다.

Aspen Pharmacare Holdings은(는) 지난 7년 동안 매년 배당금을 지급했습니다.

향후 12개월 동안 4.05 ZAR의 배당금이 예상됩니다. 이는 배당수익률 0.04 %에 해당합니다.

Aspen Pharmacare Holdings은 '건강' 섹터에 속합니다.

Aspen Pharmacare Holdings의 마지막 배당금을 0.2 ZAR만큼 받기 위해선 의 Ex-Tag 전에 주식을 보유하고 있어야 했습니다.

마지막 배당금 지급일은 입니다.

2024년에 Aspen Pharmacare Holdings는 3.42 ZAR를 배당금으로 지급했습니다.

Aspen Pharmacare Holdings의 배당금은 ZAR에 지급됩니다.